Moffitt Focuses On Ovarian Cancer During Gynecologic Cancer Awareness Month

September 06th, 2007 | Category: Cancer

Doctors and researchers at Moffitt Cancer Center are harnessing the potential of genomic technology to personalize cancer care for women with gynecologic malignancies by matching the right patient with the right drug. “Although there are many drugs available

to treat ovarian cancer, only a small proportion of patients benefit from each drug,” said Dr. Johnathan Lancaster, Ph.D. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Simple Blood analysis For BRCA Gene Mutation Helps Save Lives
  • Moffitt Looking To Talk To Hispanic Women For Genetic Awareness Study
  • Breast Cancer Awareness Month
  • Screening Matters that Breast Cancer Awareness Month, UK
  • Ovarian Cancer: The Not-so Silent Killer

    • No comments yet. Be the first.

    Leave a reply